1. Home
  2. LINC vs TBPH Comparison

LINC vs TBPH Comparison

Compare LINC & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LINC
  • TBPH
  • Stock Information
  • Founded
  • LINC 1946
  • TBPH 2013
  • Country
  • LINC United States
  • TBPH United States
  • Employees
  • LINC 2475
  • TBPH N/A
  • Industry
  • LINC Other Consumer Services
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • LINC Real Estate
  • TBPH Health Care
  • Exchange
  • LINC Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • LINC 732.0M
  • TBPH 699.0M
  • IPO Year
  • LINC 2005
  • TBPH N/A
  • Fundamental
  • Price
  • LINC $23.26
  • TBPH $14.29
  • Analyst Decision
  • LINC Strong Buy
  • TBPH Strong Buy
  • Analyst Count
  • LINC 4
  • TBPH 4
  • Target Price
  • LINC $24.50
  • TBPH $23.00
  • AVG Volume (30 Days)
  • LINC 213.1K
  • TBPH 293.8K
  • Earning Date
  • LINC 11-10-2025
  • TBPH 11-11-2025
  • Dividend Yield
  • LINC N/A
  • TBPH N/A
  • EPS Growth
  • LINC 79.82
  • TBPH N/A
  • EPS
  • LINC 0.46
  • TBPH 0.26
  • Revenue
  • LINC $467,763,000.00
  • TBPH $77,205,000.00
  • Revenue This Year
  • LINC $14.51
  • TBPH $79.82
  • Revenue Next Year
  • LINC $8.40
  • TBPH N/A
  • P/E Ratio
  • LINC $50.82
  • TBPH $55.81
  • Revenue Growth
  • LINC 14.53
  • TBPH 24.49
  • 52 Week Low
  • LINC $12.35
  • TBPH $7.90
  • 52 Week High
  • LINC $25.76
  • TBPH $15.15
  • Technical
  • Relative Strength Index (RSI)
  • LINC 62.22
  • TBPH 54.24
  • Support Level
  • LINC $21.36
  • TBPH $13.73
  • Resistance Level
  • LINC $23.55
  • TBPH $14.38
  • Average True Range (ATR)
  • LINC 0.69
  • TBPH 0.45
  • MACD
  • LINC 0.09
  • TBPH -0.05
  • Stochastic Oscillator
  • LINC 87.20
  • TBPH 61.16

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: